Cathepsin V, His-tag Recombinant

Catalog #
80009
$385 *
Size: 10 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant human cathepsin V, encompassing amino acids 18-334(end). This construct has a  C-terminal His-tag (10xHis). This protein was affinity purified.

Synonyms
CTSV
Product Info
Storage and Usage
Citations
Species
Human
Construct
Cathepsin V (18-334(end)-His)
Host Species/Expression System
HEK293
Purity

≥79%

Format
Aqueous buffer solution
Formulation

40 mM MES, pH 5.0, 120 mM NaCl, and 20% glycerol.

MW
37 kDa + glycans
Amino Acids
CD33 1–16, CathepsinV 18–334
Glycosylation
This protein runs at a higher MW by SDS-PAGE due to glycosylation.
Specific Activity

≥ 250 pmol/min/µg

Genbank #
NM_060911
UniProt #
O60911
Tag(s)
C-terminal His-tag
Background

Cathepsin V, also called Cathepsin L2, is a lysosomal cysteine endopeptidase with high sequence homology to cathepsin L and other members of the papain superfamily of cysteine proteinases. Its expression is regulated in a tissue-specific manner and is high in thymus, heart, brain, testis, and cornea. It is involved in maturation of MHC class II molecules, turnover of elastin and breakdown of intra and extra-cellular substrates. Expression analysis of cathepsin V in human tumors revealed widespread expression in colorectal and breast carcinomas, suggesting a possible role in tumor processes. It has also been linked to atherosclerosis, hypertension, and aortic aneurysm, amongst other vascular-related pathologies. Further studies into its functions will allow us to understand in depth the potential benefits of targeting Cathepsin V for therapeutic purposes.